EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Analytical and Clinical Validity of a High-Throughput, Fully Automated Immunoassay for Plasma Neurofilament Light Chain

Dusten Unruh, Jeff Todtleben, Kara Johnson, Ben Schlichtmann, Miklos Szabo, Mark Holland, Corey Carlson, Jeremiah Hinson, Scott Levin iD

The Journal of Applied Laboratory Medicine · 2026

DOI: 10.1093/jalm/jfag052 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, 2026. Verfasst von Dusten Unruh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beckman Coulter Diagnostics, Chaska, MN, United States. Hauptthemen laut MEDLINE: Neurofilament Proteins, Multiple Sclerosis, Alzheimer Disease, High-Throughput Screening Assays. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neurofilament light chain (NfL) has emerged as a promising blood-based biomarker for neuroaxonal damage across neurological disorders. Clinical utility has been correlated with disease activity, treatment response, and prognosis. However, routine clinical laboratory implementation requires comprehensive analytical validation to ensure reliability and accuracy.

Methods

A fully automated Access NfL research use only (RUO) immunoassay was evaluated on the DxI 9000 Immunoassay Analyzer from Beckman Coulter. Analytical validation in plasma assessed precision, analytical sensitivity, linearity, analytical specificity (interference), calibrator and sample stability, and method comparison to the Quanterix Simoa NfL assay. Clinical validity included comparisons of Alzheimer disease (Ad, N = 20) in plasma and multiple sclerosis (MS, N = 16) in serum, vs healthy controls (N = 20 and N = 23, respectively). Plasma−serum equivalence was validated.

Results

The NfL assay met analytical criteria, with precision demonstrating coefficients of variation <3% across runs, a lower limit of quantification of 3.10 pg/mL, linearity with <12% deviation, and <10% interference. Plasma NfL samples remained stable for 18 h at room temperature (<7% difference) and refrigerated (<5%), and through 5 freeze−thaw cycles (<8%). Method comparison yielded high correlation (R2 = 0.981) with positive systematic proportional bias (Passing–Bablok slope = 3.02). Ad patients showed significantly elevated NfL levels (median 49.3 pg/mL, IQR: 28.9–67.8) vs controls (median 29.1 pg/mL, IQR: 22.6–33.8; P = 0.02). MS patients similarly demonstrated higher NfL (median 27.7 pg/mL, IQR: 22.5–50.6) vs controls (median 19.2 pg/mL, IQR: 15.1–25.6; P = 0.003).

Conclusions

The high-throughput Access NfL assay demonstrated analytical and clinical validity, supporting implementation in research and clinical laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofilament ProteinsMultiple SclerosisAlzheimer DiseaseHigh-Throughput Screening AssaysHumansImmunoassayReproducibility of ResultsBiomarkersFemaleSensitivity and SpecificityMale

Substanzen

Neurofilament ProteinsBiomarkersneurofilament protein L

Autor:innen und Institutionen

  • Beckman Coulter Diagnostics, Chaska, MN, United States.
  • Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Danaher Diagnostics, Washington, DC, United States.

ORCID-Profile: Scott Levin

Zitieren

APA

Unruh, D., Todtleben, J., Johnson, K., Schlichtmann, B., Szabo, M., Holland, M., Carlson, C., Hinson, J., & Levin, S. (2026). Analytical and Clinical Validity of a High-Throughput, Fully Automated Immunoassay for Plasma Neurofilament Light Chain. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfag052

Vancouver

Unruh D, Todtleben J, Johnson K, Schlichtmann B, Szabo M, Holland M, et al. Analytical and Clinical Validity of a High-Throughput, Fully Automated Immunoassay for Plasma Neurofilament Light Chain. The Journal of Applied Laboratory Medicine. 2026. doi:10.1093/jalm/jfag052

BibTeX
@article{Unruh2026,
  author = {Unruh, Dusten and Todtleben, Jeff and Johnson, Kara and Schlichtmann, Ben and Szabo, Miklos and Holland, Mark and Carlson, Corey and Hinson, Jeremiah and Levin, Scott},
  title = {Analytical and Clinical Validity of a High-Throughput, Fully Automated Immunoassay for Plasma Neurofilament Light Chain},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2026},
  doi = {10.1093/jalm/jfag052}
}
Kostenlos starten →